Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Motpoly XR (lacosamide) – New drug approval
May 4, 2023 - The FDA approved Acute Pharmaceuticals’ Motpoly XR (lacosamide), for the treatment of partial-onset seizures in adults and in pediatric patients weighing at least 50 kg.
